Arundhati Parmar
Arundhati Parmar is VP and Editor-in-Chief at MedCity News. In this role, she oversees MedCity's news coverage as well as develops the content for several conferences that the publication hosts. Previously, she was Senior Editor at UBM's Medical Device + Diagnostic Industry. Arundhati has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again. Contact her at aparmar@medcitynews.com.
LinkedIn: https://www.linkedin.com/in/arundhati-parmar/
Twitter: @aparmarbb
-
MedCity Pivot Podcast: Tackling Rare Disease With Someone Who Was Touched By It
Rich Horgan believes that there’s an alternative path to drug development that can lower costs and the time it takes to bring drugs to market. He is trying to apply it to the field of rare and ultra-rare diseases.
-
What Impact Will California’s New “Transaction Review” Law Have?
California passed a law last year aimed at controlling rising healthcare costs that gave the state the ability to scrutinize healthcare deals of a certain size involving California companies. What impact can it have?
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
MedCity Pivot Podcast: A Conversation With Unlearn.AI CEO About Clinical Trials
The founder and CEO of Unlearn.AI seeks to make clinical trials more efficient and less costly by leveraging its Digital Twin technology. If the company is successful, drugs could potentially be brought to market sooner and in a cost effective manner.
-
Here’s Why Many Americans Are Unable to Afford Their Drugs
Pharmaceutical manufacturers say high U.S. prices support research and development and point out that Americans tend to get new treatments first. But recent research has shown that the price of a drug is related neither to the amount of research and development required to bring it to market nor its therapeutic value.
-
MedCity Pivot Podcast: Season 3 Launches With A Conversation On the Potential Toxicity of Immunotherapy
Transformations in the Life Sciences is the focus of the second season of the MedCity Pivot Podcast. My personal journey as a caregiver of a cancer patient made me choose Dr. Sumanta Pal, co-director of the City of Hope’s Liver Cancer program as a guest after he co-authored an interesting study on immunotherapy that was published in the Lancet.
-
New York Signs Law To Protect State Providers Providing Abortion Drug Telemed Services to Out-of-State Patients
New York Governor Kathy Hochul signed new legislation that will protect the state’s doctors, medical providers and facilitators who prescribe abortion care telehealth services to patients outside of New York from litigation in states where abortion services are banned or restricted.
-
MedCity Pivot Podcast: 2 Perspectives on how AI Can Soothe Burnout, Burden of Prior Authorization
I interview Punit Singh Soni, CEO of Suki and Niall O’Connor, CTO, Cohere Health to evaluate two areas where AI can have an outsize impact: clinical documentation and prior authorization.
-
INVEST Digital Health Conference in Dallas Will Probe True Value and Not Fanciful Valuation
In an environment where capital isn’t as easy to access, INVEST Digital Health conference will seek to arm you with the right connections and meaningful insight to navigate an environment where ROI is king. Hear from payers, providers, startups, life sciences executives, VCs and more.
-
MedCity Pivot Podcast: It’s Time To Talk About Responsible AI
A conversation with Suchi Saria, associate professor of medicine at John Hopkins University and director of its Machine Learning and Healthcare Lab about responsible AI.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Small, Rural Communities Have Become Abortion Access Battlegrounds
The quest to enact local bans has become particularly acute in small towns, like West Wendover, Nevada, and Hobbs, New Mexico, which are situated by borders between states that have restricted abortion and states where laws preserve access.
-
How a Rural Health System Is Looking at Virtual Care and Remote Patient Monitoring
In a wide-ranging interview, Sanford Health’s president of virtual care explained how virtual care may be well suited to rural populations.
-
‘Abortion Trafficking’: Taking a Minor Out of State for an Abortion Is Now a Crime in Idaho:
The law creates a crime of “abortion trafficking” and criminalizes the “recruiting, harboring, or transporting” of minors without parental consent
-
Devices & Diagnostics, Artificial Intelligence
Season 2 of MedCity Pivot Podcast Launches with Conversation of Zephyr AI CTO
Season 2 of our MedCity Pivot Podcast launches today with a conversation about how AI can be leveraged to transform precision medicine.
-
Social Media Is Touting New Weight Loss Drugs. Are Regulators Watching?
Competition to claim a market that could be worth $100 billion a year for drugmakers alone has triggered a wave of advertising that has provoked the concern of regulators and doctors worldwide.
-
Payers Can Reform Prior Authorization to Make it Faster, Smoother But Will It Satisfy the AMA?
In a recent interview, Dr. Jesse Ehrenfeld, the president-elect at the American Medical Association, outlined how the major pain point of physicians has gone from the EHR to prior authorizations requests. But none of the individual efforts that payers are making is enough.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
